BACKGROUND: Get With the Guidelines (GWTG-R) is a data registry and quality improvement program for in-hospital cardiac arrest (IHCA). It is unknown if duration of hospital participation in GWTG-R is associated with IHCA outcomes. METHODS: We analyzed adults with IHCA from 362 hospitals participating in GWTG-R between 2000 and 2009. Using logistic regression with generalized estimating equations to account for clustering on hospital, we determined the association between duration of hospital participation in GWTG-R and patient outcomes after IHCA, adjusted for patient and arrest characteristics and secular trend. Using these methods, we also evaluated the association between duration of participation and factors previously correlated with survival after IHCA, including ECG monitored status, after-hours arrest, and time to defibrillation. RESULTS: Of 104,732 patients with IHCA, 17,646 patients (16.9%) survived to discharge. Duration of hospital participation in GWTG-R was associated with IHCA event survival (per year of participation, odds ratio [OR] 1.02; 95% CI 1.00-1.04; p=0.046) but not survival to discharge (OR 1.02; 95% CI 0.99-1.04; p=0.18). Among factors previously correlated with IHCA survival, duration of participation was associated with time to defibrillation ≤2 min (per year of participation, OR 1.06; 95% CI 1.03-1.10; p<0.001), but not ECG monitored status (OR 1.00; 95% CI 0.93-1.06; p=0.90) or survival of after-hours arrest (OR 1.01; 95% CI 0.99-1.03; p=0.41). Among ventricular tachycardia or ventricular fibrillation (VT/VF) arrests, time to defibrillation attenuated the association between duration of hospital participation and outcomes. CONCLUSION: Duration of hospital participation in GWTG-R was significantly associated with survival of the IHCA event, but not with survival to discharge. In VT/VF arrests, this association may have been mediated by improvements in time to defibrillation. Published by Elsevier Ireland Ltd.
BACKGROUND: Get With the Guidelines (GWTG-R) is a data registry and quality improvement program for in-hospital cardiac arrest (IHCA). It is unknown if duration of hospital participation in GWTG-R is associated with IHCA outcomes. METHODS: We analyzed adults with IHCA from 362 hospitals participating in GWTG-R between 2000 and 2009. Using logistic regression with generalized estimating equations to account for clustering on hospital, we determined the association between duration of hospital participation in GWTG-R and patient outcomes after IHCA, adjusted for patient and arrest characteristics and secular trend. Using these methods, we also evaluated the association between duration of participation and factors previously correlated with survival after IHCA, including ECG monitored status, after-hours arrest, and time to defibrillation. RESULTS: Of 104,732 patients with IHCA, 17,646 patients (16.9%) survived to discharge. Duration of hospital participation in GWTG-R was associated with IHCA event survival (per year of participation, odds ratio [OR] 1.02; 95% CI 1.00-1.04; p=0.046) but not survival to discharge (OR 1.02; 95% CI 0.99-1.04; p=0.18). Among factors previously correlated with IHCA survival, duration of participation was associated with time to defibrillation ≤2 min (per year of participation, OR 1.06; 95% CI 1.03-1.10; p<0.001), but not ECG monitored status (OR 1.00; 95% CI 0.93-1.06; p=0.90) or survival of after-hours arrest (OR 1.01; 95% CI 0.99-1.03; p=0.41). Among ventricular tachycardia or ventricular fibrillation (VT/VF) arrests, time to defibrillation attenuated the association between duration of hospital participation and outcomes. CONCLUSION: Duration of hospital participation in GWTG-R was significantly associated with survival of the IHCA event, but not with survival to discharge. In VT/VF arrests, this association may have been mediated by improvements in time to defibrillation. Published by Elsevier Ireland Ltd.
Authors: Ying Xian; Wenqin Pan; Eric D Peterson; Paul A Heidenreich; Christopher P Cannon; Adrian F Hernandez; Bruce Friedman; Robert G Holloway; Gregg C Fonarow Journal: Am Heart J Date: 2010-02 Impact factor: 4.749
Authors: Lee H Schwamm; Gregg C Fonarow; Mathew J Reeves; Wenqin Pan; Michael R Frankel; Eric E Smith; Gray Ellrodt; Christopher P Cannon; Li Liang; Eric Peterson; Kenneth A Labresh Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Paul S Chan; Adnan Khalid; Lance S Longmore; Robert A Berg; Mikhail Kosiborod; John A Spertus Journal: JAMA Date: 2008-12-03 Impact factor: 56.272
Authors: Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Frances C Brokaw; Janette Seville; Jay G Hull; Zhongze Li; Tor D Tosteson; Ira R Byock; Tim A Ahles Journal: JAMA Date: 2009-08-19 Impact factor: 56.272
Authors: Sean O'Mahony; Janet McHenry; Arthur E Blank; Daniel Snow; Serife Eti Karakas; Gabriella Santoro; Peter Selwyn; Vladimir Kvetan Journal: Palliat Med Date: 2009-10-13 Impact factor: 4.762
Authors: Susan L Greenspan; John P Bilezikian; Nelson B Watts; Carolyn A Berry; William A Mencia; Stephanie A Stowell; Rachel Bongiorno Karcher Journal: J Womens Health (Larchmt) Date: 2013-09-06 Impact factor: 2.681
Authors: Corey R Fehnel; Alissa Trepman; Dale Steele; Muhib A Khan; Brian Silver; Susan L Mitchell Journal: J Clin Neurosci Date: 2018-05-19 Impact factor: 1.961
Authors: Farhan Bhanji; Alexis A Topjian; Vinay M Nadkarni; Amy H Praestgaard; Elizabeth A Hunt; Adam Cheng; Peter A Meaney; Robert A Berg Journal: JAMA Pediatr Date: 2017-01-01 Impact factor: 16.193
Authors: Lauren E Thompson; Paul S Chan; Fengming Tang; Brahmajee K Nallamothu; Saket Girotra; Sarah M Perman; Somnath Bose; Stacie L Daugherty; Steven M Bradley Journal: Resuscitation Date: 2017-11-02 Impact factor: 5.262
Authors: Lars W Andersen; Mathias J Holmberg; Katherine M Berg; Michael W Donnino; Asger Granfeldt Journal: JAMA Date: 2019-03-26 Impact factor: 56.272
Authors: Keith Couper; Peter K Kimani; Benjamin S Abella; Mehboob Chilwan; Matthew W Cooke; Robin P Davies; Richard A Field; Fang Gao; Sarah Quinton; Nigel Stallard; Sarah Woolley; Gavin D Perkins Journal: Crit Care Med Date: 2015-11 Impact factor: 7.598